Soohyun Hwang - Search Results

Year	Number of Results
2004	1
2007	1
2013	2
2014	4
2015	3
2016	3
2017	2
2019	4
2020	8
2021	7
2022	9
2023	11
2024	6

1

Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung cancer.

Park S, Hong TH, Hwang S, Heeke S, Gay CM, Kim J, Jung HA, Sun JM, Ahn JS, Ahn MJ, Cho JH, Choi YS, Kim J, Shim YM, Kim HK, Byers LA, Heymach JV, Choi YL, Lee SH, Park K. Park S, et al. Among authors: hwang s. EBioMedicine. 2024 Apr;102:105062. doi: 10.1016/j.ebiom.2024.105062. Epub 2024 Mar 15. EBioMedicine. 2024. PMID: 38492534 Free PMC article.

2

PD-L1 expression in resected lung adenocarcinoma: prevalence and prognostic significance in relation to the IASLC grading system.

Hwang S, Hong TH, Kim HK, Cho J, Lee G, Choi S, Park S, Lee SH, Lee Y, Jeon YJ, Lee J, Park SY, Cho JH, Choi YS, Kim J, Zo JI, Shim YM, Choi YL. Hwang S, et al. Histopathology. 2024 May;84(6):1013-1023. doi: 10.1111/his.15146. Epub 2024 Jan 30. Histopathology. 2024. PMID: 38288635

3

Clinicopathological and Molecular Characteristics of IDH-Wildtype Glioblastoma with FGFR3::TACC3 Fusion.

Bae H, Lee B, Hwang S, Lee J, Kim HS, Suh YL. Bae H, et al. Among authors: hwang s. Biomedicines. 2024 Jan 10;12(1):150. doi: 10.3390/biomedicines12010150. Biomedicines. 2024. PMID: 38255255 Free PMC article.

4

Diagnostic utility of genetic alterations in distinguishing IDH-wildtype glioblastoma from lower-grade gliomas: Insight from next-generation sequencing analysis of 479 cases.

Lee B, Hwang S, Bae H, Choi KH, Suh YL. Lee B, et al. Among authors: hwang s. Brain Pathol. 2024 Jan 12:e13234. doi: 10.1111/bpa.13234. Online ahead of print. Brain Pathol. 2024. PMID: 38217295

5

Clinical Significance of the Proposed Pathologic Criteria for Invasion by the International Association for the Study of Lung Cancer in Resected Nonmucinous Lung Adenocarcinoma.

Hong TH, Hwang S, Cho J, Choi YL, Han J, Lee G, Jeon YJ, Lee J, Park SY, Cho JH, Choi YS, Kim J, Shim YM, Kim HK. Hong TH, et al. Among authors: hwang s. J Thorac Oncol. 2024 Mar;19(3):425-433. doi: 10.1016/j.jtho.2023.10.013. Epub 2023 Nov 2. J Thorac Oncol. 2024. PMID: 37924973

6

Distinct Recurrence Pattern and Survival Outcomes of Invasive Mucinous Adenocarcinoma of the Lung: The Potential Role of Local Therapy in Intrapulmonary Spread.

Yoon DW, Hwang S, Hong TH, Choi YL, Kim HK, Choi YS, Kim J, Shim YM, Cho JH. Yoon DW, et al. Among authors: hwang s. Ann Surg Oncol. 2024 Jan;31(1):201-212. doi: 10.1245/s10434-023-14373-8. Epub 2023 Oct 9. Ann Surg Oncol. 2024. PMID: 37814186

7

Author Correction: In vivo silencing of amphiregulin by a novel effective Self-Assembled-Micelle inhibitory RNA ameliorates renal fibrosis via inhibition of EGFR signals.

Son SS, Hwang S, Park JH, Ko Y, Yun SI, Lee JH, Son B, Kim TR, Park HO, Lee EY. Son SS, et al. Among authors: hwang s. Sci Rep. 2023 Jul 20;13(1):11745. doi: 10.1038/s41598-023-38689-3. Sci Rep. 2023. PMID: 37474641 Free PMC article. No abstract available.

8

Patterns of multispecialty care for low- and intermediate-risk prostate cancer in the use of active surveillance.

Zambrano IA, Hwang S, Basak R, Spratte BN, Filson CP, Jacobs BL, Tan HJ. Zambrano IA, et al. Among authors: hwang s. Urol Oncol. 2023 Sep;41(9):388.e1-388.e8. doi: 10.1016/j.urolonc.2023.04.024. Epub 2023 Jun 5. Urol Oncol. 2023. PMID: 37286404

9

Use of expectant management based on prostate cancer risk and health status: How far are we from a risk-adapted approach?

Spratte BN, Tan HJ, Zambrano IA, Basak RS, Filson CP, Jacobs BL, Hwang S. Spratte BN, et al. Among authors: hwang s. Urol Oncol. 2023 Jul;41(7):323.e17-323.e25. doi: 10.1016/j.urolonc.2023.04.006. Epub 2023 May 5. Urol Oncol. 2023. PMID: 37149430

10

Exploring the Acceptability of Text Messages to Inform and Support Shared Decision-making for Colorectal Cancer Screening: Online Panel Survey.

Hwang S, Lazard AJ, Reffner Collins MK, Brenner AT, Heiling HM, Deal AM, Crockett SD, Reuland DS, Elston Lafata J. Hwang S, et al. JMIR Cancer. 2023 May 5;9:e40917. doi: 10.2196/40917. JMIR Cancer. 2023. PMID: 37145859 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

54 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year